Eric Coldwell
Stock Analyst at Baird
(4.20)
# 562
Out of 4,412 analysts
97
Total ratings
61.84%
Success rate
9.71%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Laboratory Corporation of America Holdings | Maintains: Outperform | $255 → $244 | $198.40 | +22.98% | 7 | Apr 26, 2024 | |
| ICLR ICON PLC | Maintains: Outperform | $362 → $363 | $308.31 | +17.74% | 10 | Apr 26, 2024 | |
| MEDP Medpace Holdings | Maintains: Outperform | $446 → $454 | $395.93 | +14.67% | 9 | Apr 24, 2024 | |
| OMI Owens & Minor | Maintains: Neutral | $24 → $28 | $25.09 | +11.60% | 8 | Apr 10, 2024 | |
| FTRE Fortrea Holdings | Initiates: Neutral | $43 | $36.35 | +18.29% | 1 | Mar 22, 2024 | |
| IQV IQVIA Holdings | Maintains: Neutral | $226 → $251 | $234.88 | +6.86% | 7 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Maintains: Outperform | $252 → $268 | $229.03 | +17.02% | 5 | Feb 15, 2024 | |
| CTLT Catalent | Upgrades: Outperform | $45 → $53 | $55.92 | -5.22% | 1 | Nov 16, 2023 | |
| PINC Premier | Maintains: Neutral | $30 → $24 | $20.96 | +14.50% | 3 | Aug 24, 2023 | |
| CAH Cardinal Health | Maintains: Outperform | $107 → $108 | $103.21 | +4.64% | 7 | Aug 16, 2023 | |
| AHCO AdaptHealth | Maintains: Outperform | $20 → $21 | $9.96 | +110.84% | 8 | Jul 13, 2023 | |
| MCK McKesson | Maintains: Outperform | $450 → $475 | $543.30 | -12.57% | 8 | May 9, 2023 | |
| DGX Quest Diagnostics | Maintains: Neutral | $143 → $154 | $134.26 | +14.70% | 2 | Jan 12, 2023 | |
| WBA Walgreens Boots Alliance | Downgrades: Neutral | $51 | $17.70 | +188.14% | 15 | Apr 1, 2022 | |
| FUL H.B. Fuller Company | Maintains: Neutral | n/a | $74.23 | - | 1 | Mar 27, 2020 | |
| CVS CVS Health | Maintains: Neutral | n/a | $67.18 | - | 3 | Mar 27, 2020 | |
| INCR InterCure | Maintains: Outperform | n/a | $2.65 | - | 2 | Nov 10, 2017 |
Laboratory Corporation of America Holdings
Apr 26, 2024
Maintains: Outperform
Price Target: $255 → $244
Current: $198.40
Upside: +22.98%
ICON PLC
Apr 26, 2024
Maintains: Outperform
Price Target: $362 → $363
Current: $308.31
Upside: +17.74%
Medpace Holdings
Apr 24, 2024
Maintains: Outperform
Price Target: $446 → $454
Current: $395.93
Upside: +14.67%
Owens & Minor
Apr 10, 2024
Maintains: Neutral
Price Target: $24 → $28
Current: $25.09
Upside: +11.60%
Fortrea Holdings
Mar 22, 2024
Initiates: Neutral
Price Target: $43
Current: $36.35
Upside: +18.29%
IQVIA Holdings
Feb 15, 2024
Maintains: Neutral
Price Target: $226 → $251
Current: $234.88
Upside: +6.86%
Charles River Laboratories International
Feb 15, 2024
Maintains: Outperform
Price Target: $252 → $268
Current: $229.03
Upside: +17.02%
Catalent
Nov 16, 2023
Upgrades: Outperform
Price Target: $45 → $53
Current: $55.92
Upside: -5.22%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $30 → $24
Current: $20.96
Upside: +14.50%
Cardinal Health
Aug 16, 2023
Maintains: Outperform
Price Target: $107 → $108
Current: $103.21
Upside: +4.64%
AdaptHealth
Jul 13, 2023
Maintains: Outperform
Price Target: $20 → $21
Current: $9.96
Upside: +110.84%
McKesson
May 9, 2023
Maintains: Outperform
Price Target: $450 → $475
Current: $543.30
Upside: -12.57%
Quest Diagnostics
Jan 12, 2023
Maintains: Neutral
Price Target: $143 → $154
Current: $134.26
Upside: +14.70%
Walgreens Boots Alliance
Apr 1, 2022
Downgrades: Neutral
Price Target: $51
Current: $17.70
Upside: +188.14%
H.B. Fuller Company
Mar 27, 2020
Maintains: Neutral
Price Target: n/a
Current: $74.23
Upside: -
CVS Health
Mar 27, 2020
Maintains: Neutral
Price Target: n/a
Current: $67.18
Upside: -
InterCure
Nov 10, 2017
Maintains: Outperform
Price Target: n/a
Current: $2.65
Upside: -